Research indicates that a single dose of nitisinone, a drug typically used for genetic metabolic disorders, can make an individual's blood deadly to mosquitoes for a remarkable five days. This finding has significant implications for public health, particularly in combating malaria, as it suggests a novel approach could be employed to dramatically reduce mosquito survival rates and, consequently, malaria transmission rates in vulnerable populations.
Nitisinone could render a person's blood lethal to mosquitoes for five days, representing a groundbreaking method in the fight against malaria and its spread.
Modelling suggests that a single dose of nitisinone, a drug for metabolic disorders, could significantly reduce malaria transmission by affecting mosquito survival.
Collection
[
|
...
]